{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:36:29Z","timestamp":1790429789441,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clim.2012.10.008","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T04:04:35Z","timestamp":1352261075000},"page":"15-25","source":"Crossref","is-referenced-by-count":42,"title":["TNF-\u03b1 is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression"],"prefix":"10.1016","volume":"146","author":[{"given":"Satoru","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayo","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Maruoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.10.008_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.23.021704.115719","article-title":"Network communications: lymphotoxins, LIGHT, and TNF","volume":"23","author":"Ware","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","article-title":"TNF alpha blockade in human diseases: mechanisms and future directions","volume":"126","author":"Wong","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNF alpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.clim.2012.10.008_bb0025","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-\u03b1-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.clim.2012.10.008_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00005176-199501000-00005","article-title":"Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis","volume":"20","author":"Maggiore","year":"1995","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.clim.2012.10.008_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","article-title":"Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmunehepatitis","volume":"117","author":"Czaja","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2012.10.008_bb0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2012.10.008_bb0050","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.166.10.6413","article-title":"Genetic regulation of autoimmune disease: BALB\/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis","volume":"166","author":"Gorham","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0055","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.0803417","article-title":"End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-\u03b3 but is independent of Fas","volume":"182","author":"Robinson","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0060","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/art.23674","article-title":"Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator","volume":"58","author":"Oya","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.10.008_bb0065","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.10.008_bb0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clim.2005.08.010","article-title":"Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12","volume":"117","author":"Tamaki","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0075","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2012.10.008_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2012.10.008_bb0085","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6","volume":"179","author":"Mizuhara","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.10.008_bb0090","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.159.3.1418","article-title":"Suppression of concanavalin A-induced hepatitis in IFN-\u03b3(\u2212\/\u2212) mice, but not in TNF-\u03b1(\u2212\/\u2212) mice: role for IFN-\u03b3 in activating apoptosis of hepatocytes","volume":"159","author":"Tagawa","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2012.10.008_bb0100","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1053\/j.gastro.2011.01.002","article-title":"Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice","volume":"140","author":"Aoki","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2012.10.008_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.clim.2012.10.008_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.clim.2012.10.008_bb0115","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/onc.2008.199","article-title":"Parkin as a tumor suppressor gene for hepatocellular carcinoma","volume":"27","author":"Fujiwara","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2012.10.008_bb0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4049\/jimmunol.158.3.1033","article-title":"Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3\u03b1 and MIP-3\u03b2","volume":"158","author":"Rossi","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C\u2013C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0130","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.4049\/jimmunol.168.11.5621","article-title":"Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation","volume":"168","author":"Sugita","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/jhep.2001.26631","article-title":"CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver","volume":"34","author":"Shimizu","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2012.10.008_bb0140","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4049\/jimmunol.172.3.1588","article-title":"IFN-\u03b3 promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells","volume":"172","author":"Roth","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.10.008_bb0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.clim.2012.10.008_bb0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.clim.2012.10.008_bb0155","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/ajg.2009.433","article-title":"A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade","volume":"104","author":"Weiler-Normann","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2012.10.008_bb0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2012.10.008_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/11586210-000000000-00000","article-title":"Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab","volume":"24","author":"Cravo","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.clim.2012.10.008_bb0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/cbr.2010.0806","article-title":"A case of Rituximab-induced hepatitis","volume":"25","author":"Del Prete","year":"2010","journal-title":"Cancer Biother. Radiopharm."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T10:21:10Z","timestamp":1745144470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661612002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1521661612002641"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.10.008","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}